Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Bansk Group $1.5 billion going-private acquisition of PetIQ
We are advising Bansk Group on the transaction
Revolution Medicines $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
AC Immune $80 million at-the-market offering
We advised AC Immune on the offering
Adecoagro cash tender offer
We advised the company on the tender offer
Southwest Gas Holdings $340 million at-the-market offering
The shares are listed on the New York Stock Exchange
SGH $175 million convertible notes offering and capped call transactions
The 2% convertible senior notes are due 2030
MicroStrategy $2 billion at-the-market offering
The stock is listed on the Nasdaq Global Select Market
Banco Santander $1.5 billion Tier 1 capital securities offering
We advised Banco Santander on its SEC-registered offering of contingent convertible securities
Synchrony Financial $750 million senior notes offering
The investment-grade notes are due 2030
Eastman Chemical $500 million notes offering and concurrent cash tender offer
The investment-grade notes are due 2029